Mar 2025 Monthly Report

Dear Shareholder, DMXCP’s NAV declined 6.7% (after all accrued fees and expenses) for March 2026. The NAV as at 31 March 2026 was $2.7682, compared to $2.9666 as at 28 February 2026. March was a challenging month for markets, with the hostilities in the Middle East...

Mar 2026 Monthly Report

Dear Investor, DMXASF’s NAV declined 8.0% in March, adding to losses from February in a continued tough market environment. Investor sentiment has been weakened by uncertainty arising from the Middle East conflict and its ripple effect on global supply chains and...

Feb 2026 Monthly Report

Dear Investor, DMXASF’s NAV decreased 4.0% in February in a market that continues to be very mixed. The ASX 200 Accumulation Index rose 4.1%, while the ASX Small Ordinaries fell 2.6%. Technology companies fell meaningfully as concerns around AI impacted investor...

Feb 2025 Monthly Report

Dear Shareholder, DMXCP’s NAV declined 0.8% (after all accrued fees and expenses) for February 2026. The NAV as at 28 February 2026 was $2.9666, compared to $2.9896 as at 31 January 2026. During February, the All-Ordinaries Accumulation Index increased  4.1%, the...

Jan 2025 Monthly Report

Dear Shareholder, DMXCP’s NAV decreased 0.9% (after all accrued fees and expenses) for January 2026. The NAV as at 31 January 2026 was $2.9896, compared to $3.0182 as at 31 December 2025. During January, the All-Ordinaries Accumulation Index increased  1.8%, the Small...